NEW YORK, Nov. 12, 2025 ( GLOBE NEWSWIRE ) -- LB Pharmaceuticals Inc ( &#34;LB Pharmaceuticals&#34; or the &#34;Company&#34; ) ( Nasdaq: LBRX ) today announced that it has granted to James Rawls, the new Senior Vice President of Regulatory Affairs of LB Pharmaceuticals, an equity award outside of, but subject ...

LBRX

<p>紐約，2025 年 11 月 12 日（GLOBE NEWSWIRE）-- LB Pharmaceuticals Inc（“LB Pharmaceuticals” 或 “公司”）（納斯達克：LBRX）今天宣佈，已向 LB Pharmaceuticals 的新任監管事務高級副總裁 James Rawls 授予了一項股權獎勵，該獎勵不在</p>

LB Pharmaceuticals 根據納斯達克上市規則 5635(c)(4) 向新員工授予了激勵股權